Cystic fibrosis drug company to re-engage with HSE on price of Orkambi
Vertex has responded to calls from the HSE with a view to re-engage on the pricing of cystic fibrosis drug Orkambi.
Vertex has responded to calls from the HSE with a view to re-engage on the pricing of cystic fibrosis drug Orkambi.